(1)
Şanlı, F.; Barlak, N.; Kılınç, A.; Çapık, Özel; Aytatlı, A.; Karatas, O. F. The AKT Antagonist AZD5363 Suppresses Features Associated With Cancer Progression in Human Larynx Cancer Cells. Eur Res J 2020, 6 (5), 380-387. https://doi.org/10.18621/eurj.624088.